Evidence map›Paper›PMID 38776081›Full record

ArticleJAMA network open2024

Assessing the Risk of Bias in Randomized Clinical Trials With Large Language Models.

Honghao Lai, Long Ge, Mingyao Sun, Bei Pan, Jiajie Huang, Liangying Hou, Qiuyu Yang, Jiayi Liu, Jianing Liu, Ziying Ye and 8 more

Abstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Review
  10. Cardiac energetics in health and disease: a meta-analysis.European heart journal. Imaging methods and practice · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Honghao LaiDepartment of Health Policy and Management, School of Public Health, Lanzhou University, Lanzhou, China.
Long GeDepartment of Health Policy and Management, School of Public Health, Lanzhou University, Lanzhou, China.
Mingyao SunEvidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou, China.
Bei PanEvidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Jiajie HuangCollege of Nursing, Gansu University of Chinese Medicine, Lanzhou, China.
Liangying HouEvidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Qiuyu YangDepartment of Health Policy and Management, School of Public Health, Lanzhou University, Lanzhou, China.
Jiayi LiuDepartment of Health Policy and Management, School of Public Health, Lanzhou University, Lanzhou, China.
Jianing LiuCollege of Nursing, Gansu University of Chinese Medicine, Lanzhou, China.
Ziying YeDepartment of Health Policy and Management, School of Public Health, Lanzhou University, Lanzhou, China.
Danni XiaDepartment of Health Policy and Management, School of Public Health, Lanzhou University, Lanzhou, China.
Weilong ZhaoDepartment of Health Policy and Management, School of Public Health, Lanzhou University, Lanzhou, China.
Xiaoman WangEvidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Ming LiuEvidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Jhalok Ronjan TalukdarDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada.
Jinhui TianKey Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, China.
Kehu YangKey Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, China.
Janne EstillEvidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Large language models (LLMs) may facilitate the labor-intensive process of systematic reviews. However, the exact methods and reliability remain uncertain. Objective: To explore the feasibility and reliability of using LLMs to assess risk of bias (ROB) in randomized clinical trials (RCTs). Design, Setting, and Participants: A survey study was conducted between August 10, 2023, and October 30, 2023. Thirty RCTs were selected from published systematic reviews. Main Outcomes and Measures: A structured prompt was developed to guide ChatGPT (LLM 1) and Claude (LLM 2) in assessing the ROB in these RCTs using a modified version of the Cochrane ROB tool developed by the CLARITY group at McMaster University. Each RCT was assessed twice by both models, and the results were documented. The results were compared with an assessment by 3 experts, which was considered a criterion standard. Correct assessment rates, sensitivity, specificity, and F1 scores were calculated to reflect accuracy, both overall and for each domain of the Cochrane ROB tool; consistent assessment rates and Cohen κ were calculated to gauge consistency; and assessment time was calculated to measure efficiency. Performance between the 2 models was compared using risk differences. Results: Both models demonstrated high correct assessment rates. LLM 1 reached a mean correct assessment rate of 84.5% (95% CI, 81.5%-87.3%), and LLM 2 reached a significantly higher rate of 89.5% (95% CI, 87.0%-91.8%). The risk difference between the 2 models was 0.05 (95% CI, 0.01-0.09). In most domains, domain-specific correct rates were around 80% to 90%; however, sensitivity below 0.80 was observed in domains 1 (random sequence generation), 2 (allocation concealment), and 6 (other concerns). Domains 4 (missing outcome data), 5 (selective outcome reporting), and 6 had F1 scores below 0.50. The consistent rates between the 2 assessments were 84.0% for LLM 1 and 87.3% for LLM 2. LLM 1's κ exceeded 0.80 in 7 and LLM 2's in 8 domains. The mean (SD) time needed for assessment was 77 (16) seconds for LLM 1 and 53 (12) seconds for LLM 2. Conclusions: In this survey study of applying LLMs for ROB assessment, LLM 1 and LLM 2 demonstrated substantial accuracy and consistency in evaluating RCTs, suggesting their potential as supportive tools in systematic review processes.

Indexed as

BiasRandomized Controlled Trials as TopicHumansLanguageReproducibility of ResultsRisk Assessment

Identifiers

PMID38776081
PMCPMC11112444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.